Product NDC: | 50111-884 |
Proprietary Name: | Metronidazole |
Non Proprietary Name: | Metronidazole |
Active Ingredient(s): | 375 mg/1 & nbsp; Metronidazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50111-884 |
Labeler Name: | Pliva |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076522 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090930 |
Package NDC: | 50111-884-05 |
Package Description: | 50 CAPSULE in 1 BOTTLE (50111-884-05) |
NDC Code | 50111-884-05 |
Proprietary Name | Metronidazole |
Package Description | 50 CAPSULE in 1 BOTTLE (50111-884-05) |
Product NDC | 50111-884 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metronidazole |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090930 |
Marketing Category Name | ANDA |
Labeler Name | Pliva |
Substance Name | METRONIDAZOLE |
Strength Number | 375 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient] |